Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this study is to estimate the overall response rate (ORR) for patients receiving pemetrexed in combination with LY2603618 for advanced or metastatic non-small cell lung cancer (NSCLC) after 1 prior therapy for their disease
Inclusion criteria
- Advanced or metastatic non-squamous second-line Non-small cell lung cancer